Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
27.15
52.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Dizal Jiangsu Pharmaceutical Co Ltd
Total Liabilities & Equity
Dizal Jiangsu Pharmaceutical Co Ltd
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
D
|
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
|
Total Liabilities & Equity
ÂĄ1.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Total Liabilities & Equity
ÂĄ41.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Liabilities & Equity
ÂĄ20.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Akeso Inc
HKEX:9926
|
Total Liabilities & Equity
ÂĄ5.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Total Liabilities & Equity
ÂĄ15.7B
|
CAGR 3-Years
65%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Total Liabilities & Equity
ÂĄ54.8B
|
CAGR 3-Years
32%
|
CAGR 5-Years
43%
|
CAGR 10-Years
36%
|
See Also
What is Dizal Jiangsu Pharmaceutical Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
1.5B
CNY
Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Total Liabilities & Equity amounts to 1.5B CNY.
What is Dizal Jiangsu Pharmaceutical Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
19%
Over the last year, the Total Liabilities & Equity growth was -28%. The average annual Total Liabilities & Equity growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 8% over the past three years , 19% over the past five years .